Harrow To Participate In Two Investor Conferences In November
Craig-Hallum 17 th Annual Alpha Select Conference
- Format: 1x1 investor meetings Date: Tuesday, November 17, 2026 Location: New York, NY
2026 Jefferies Global Healthcare Conference
- Format: Presentation and 1x1 investor meetings Date/Time: Wednesday, November 18, 2026 at 8:00 a.m. GMT (3:00 a.m. ET) Location: London, UK
The Jefferies presentation will be webcast live and can be accessed on the Events page of the Company's website. A replay of the webcast will be available for approximately 90 days following the presentation. Investors interested in meeting with management during either of these conferences should contact their representative at the sponsoring firm to request a meeting.
About Harrow
Harrow, Inc. (Nasdaq: HROW) is a leading provider of ophthalmic disease management solutions in North America, offering a comprehensive portfolio of products that address conditions affecting both the front and back of the eye, such as dry eye disease, wet (or neovascular) age-related macular degeneration, cataracts, refractive errors, glaucoma and a range of other ocular surface conditions and diseases of the retina. Harrow was founded with a commitment to deliver safe, effective, accessible, and affordable medications that enhance patient compliance and improve clinical outcomes. For more information about Harrow, please visit harrow.com and connect with us on LinkedIn.
Contact:
Mike Biega
Vice President of Investor Relations and Communications
...
617-913-8890
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment